The report analyzes and forecasts the cancer cachexia market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of cancer cachexia, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major cancer cachexia companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of cancer cachexia upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of cancer cachexia and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global cancer cachexia market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the cancer cachexia market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of cancer cachexia market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Few of the major market competitors currently working in the Æterna Zentaris Inc., Alder BioPharmaceuticals Inc., Aphios Corp., Eli Lilly and Co., GTx Inc., Helsinn Group, Merck & Co. Inc., Novartis AG, Bristol-Myers Squibb Co., XBiotech Inc., Marsala Biotech Inc., Inovio Pharmaceuticals, Inc., Inc., Astellas Pharma Inc., AstraZeneca PLC, Biotest AG, Boehringer Ingelheim GmbH, Boston Biomedical, InteRNA Technologies B.V., ISU ABXIS Co.,Ltd., AVEO Pharmaceuticals, Inc and Jiangsu Kanion Pharmaceutical Co., Ltd. among others.
Segmentation: Global Cancer Cachexia Market
By Therapeutics
Progestogens
Corticosteroids
Combination Therapies
Others
By Mechanism of action
Appetite Stimulators
Weight Loss Stabilizers
Others
By Distribution Channel
Hospital Stores
Retail Pharmacy Stores
Online Pharmacy
By Geography
North America
South America
Europe
Asia-Pacific
Middle East and Africa
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
2. Assumptions and Research Methodology
3. Executive Summary: Global Cancer Cachexia Market
4. Market Overview
4.1. Introduction
4.1.1. Therapeutics Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.5. Global Cancer Cachexia Market Analysis and Forecasts, 2014-2024
4.5.1. Market Revenue Projections (US$ Mn)
4.6. Cancer Cachexia Market - Global Supply Demand Scenario
4.7. Porter’s Five Force Analysis
4.8. Regulatory Scenario
4.9. Cancer Cachexia – Incidence Rate
4.10. Cancer Cachexia – Therapeutic Approach
4.11. Cancer Cachexia Market: Pipeline Analysis
4.11.1. Phase III drugs (Forecast from approval year to 2024)
4.11.2. Phase I and Phase II drugs (Qualitative Information)
5. Global Cancer Cachexia Market Analysis and Forecasts, By Therapeutics
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Forecast by Therapeutics, 2017–2026
5.4.1. Progestogens
5.4.2. Corticosteroids
5.4.3. Combination therapies
5.5. Market Attractiveness by Therapeutics
6. Global Cancer Cachexia Market Analysis and Forecasts, By Mechanism of action
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Value Forecast by Mechanism of action, 2017–2026
6.4.1. Appetite Stimulators
6.4.2. Weight loss stabilizers
6.4.3. Others
6.5. Market Attractiveness by Mechanism of action
7. Global Cancer Cachexia Market Analysis and Forecasts, By Distribution Channels
7.1. Introduction & Definition
7.3. Key Trends
7.4. Market Value Forecast by Distribution Channels, 2017–2026
7.4.1. Hospital Stores
7.4.2. Retails Pharmacy Store
7.4.3. Online Pharmacy
7.5. Market Attractiveness by Distribution Channels
8. Global Cancer Cachexia Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Policies and Regulations
8.3. Market Value Forecast by Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East and Africa
8.4. Market Attractiveness by Country/Region
9. North America Cancer Cachexia Market Analysis and Forecast
9.1. Introduction
9.1.2. Policies and Regulations
9.1.3. Key Trends
9.2. Market Value Forecast by Therapeutics, 2017–2026
9.2.1. Progestogens
9.2.2. Corticosteroids
9.2.3. Combination therapies
9.3. Market Value Forecast by Mechanism of action, 2017–2026
9.3.1. Appetite Stimulators
9.3.2. Weight loss stabilizers
9.3.3. Others
9.4. Market Value Forecast by Distribution Channels,
9.4.1. Hospital Stores
9.4.2. Retails Pharmacy Store
9.4.3. Online Pharmacy
9.5. Market Value Forecast by Country, 2017–2026
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Therapeutics
9.6.2. By Mechanism of action
9.6.3. By Distribution Channels
9.6.4. By Country
10. Europe Cancer Cachexia Market Analysis and Forecast
10.1. Introduction
10.1.2. Policies and Regulations
10.1.3. Key Trends
10.2. Market Value Forecast by Therapeutics, 2017–2026
10.2.1. Progestogens
10.2.2. Corticosteroids
10.2.3. Combination therapies
10.3. Market Value Forecast by Mechanism of action, 2017–2026
10.3.1. Appetite Stimulators
10.3.2. Weight loss stabilizers
10.3.3. Others
10.4. Market Value Forecast by Distribution Channels,
10.4.1. Hospital Stores
10.4.2. Retails Pharmacy Store
10.4.3. Online Pharmacy
10.5. Market Value Forecast by Country, 2017–2026
10.5.1. U.K.
10.5.2. Germany
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Russia
10.5.7. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Therapeutics
10.6.2. By Mechanism of action
10.6.3. By Distribution Channels
10.6.4. By Country
11. Asia-Pacific Cancer Cachexia Market Analysis and Forecast
11.1. Introduction
11.1.1. Policies and Regulations
11.1.2. Key Trends
11.2. Market Value Forecast by Therapeutics, 2017–2026
11.2.1. Progestogens
11.2.2. Corticosteroids
11.2.3. Combination therapies
11.3. Market Value Forecast by Mechanism of action, 2017–2026
11.3.1. Appetite Stimulators
11.3.2. Weight loss stabilizers
11.3.3. Others
11.4. Market Value Forecast by Distribution Channels,
11.4.1. Hospital Stores
11.4.2. Retails Pharmacy Store
11.4.3. Online Pharmacy
11.5. Market Value Forecast by Country, 2017–2026
11.5.1. India
11.5.2. China
11.5.3. Japan
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia-Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Therapeutics
11.6.2. By Mechanism of action
11.6.3. By Distribution Channels
11.6.4. By Country
12. Latin America Cancer Cachexia Market Analysis and Forecast
12.1. Introduction
12.1.2. Policies and Regulations
12.1.3. Key Trends
12.2. Market Value Forecast by Therapeutics, 2017–2026
12.2.1. Progestogens
12.2.2. Corticosteroids
12.2.3. Combination therapies
12.3. Market Value Forecast by Mechanism of action, 2017–2026
12.3.1. Appetite Stimulators
12.3.2. Weight loss stabilizers
12.3.3. Others
12.4. Market Value Forecast by Distribution Channels,
12.4.1. Hospital Stores
12.4.2. Retails Pharmacy Store
12.4.3. Online Pharmacy
12.5. Market Value Forecast by Country, 2017–2026
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Therapeutics
12.6.2. By Mechanism of action
12.6.3. By Distribution Channels
12.6.4. By Country
13. Middle East and Africa Cancer Cachexia Market Analysis and Forecast
13.1. Introduction
13.1.2. Policies and Regulations
13.1.3. Key Trends
13.2. Market Value Forecast by Therapeutics, 2017–2026
13.2.1. Progestogens
13.2.2. Corticosteroids
13.2.3. Combination therapies
13.2.4. Others
13.3. Market Value Forecast by Mechanism of action, 2017–2026
13.3.1. Appetite Stimulators
13.3.2. Weight loss stabilizers
13.3.3. Others
13.4. Market Value Forecast by Distribution Channels,
13.4.1. Hospital Stores
13.4.2. Retails Pharmacy Store
13.4.3. Online Pharmacy
13.5. Market Value Forecast by Country, 2017–2026
13.5.1. South Africa
13.5.2. GCC Countries
13.5.3. Rest of Middle East and Africa
13.6. Market Attractiveness Analysis
13.6.1. By Therapeutics
13.6.2. By Mechanism of action
13.6.3. By Distribution Channels
13.6.4. By Country
14. Competition Landscape
14.1. Market Competition Analysis by Company (2016)
14.2. Company Profiles
14.2.1. Æterna Zentaris Inc.
14.2.1.1. Overview (HQ, Employee Strength, Business Segments)
14.2.1.2. Financials
14.2.1.3. Recent Development
14.2.1.4. Strategy
14.2.2. Alder BioPharmaceuticals Inc.
14.2.2.1. Overview (HQ, Employee Strength, Business Segments)
14.2.2.2. Financials
14.2.2.3. Recent Development
14.2.2.4. Strategy
14.2.3. Aphios Corporation
14.2.3.1. Overview (HQ, Employee Strength, Business Segments)
14.2.3.2. Financials
14.2.3.3. Recent Development
14.2.3.4. Strategy
14.2.4. Eli Lilly and Company
14.2.4.1. Overview (HQ, Employee Strength, Business Segments)
14.2.4.2. Financials
14.2.4.3. Recent Development
14.2.4.4. Strategy
14.2.5. GTx, Inc.
14.2.5.1. Overview (HQ, Employee Strength, Business Segments)
14.2.5.2. Financials
14.2.5.3. Recent Development
14.2.5.4. Strategy
14.2.6. Helsinn Group
14.2.6.1. Overview (HQ, Employee Strength, Business Segments)
14.2.6.2. Financials
14.2.6.3. Recent Development
14.2.6.4. Strategy
14.2.7. Merck & Co., Inc.
14.2.7.1. Overview (HQ, Employee Strength, Business Segments)
14.2.7.2. Financials
14.2.7.3. Recent Development
14.2.7.4. Strategy
14.2.8. Novartis AG
14.2.8.1. Overview (HQ, Employee Strength, Business Segments)
14.2.8.2. Financials
14.2.8.3. Recent Development
14.2.8.4. Strategy
14.2.9. Bristol-Myers Squibb Company
14.2.9.1. Overview (HQ, Employee Strength, Business Segments)
14.2.9.2. Financials
14.2.9.3. Recent Development
14.2.9.4. Strategy
14.2.10. XBiotech, Inc.
14.2.10.1. Overview (HQ, Employee Strength, Business Segments)
14.2.10.2. Financials
14.2.10.3. Recent Development
14.2.10.4. Strategy
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers